A2667 - Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study
Presenter:
Date
05/20/2019
Room
Room D222-D224 (Level 2), KBHCCD
Session Name
B21 - SEVERE ASTHMA: CLINICAL AND MECHANISTIC STUDIES
A6621 - Cryptococcus: The Ultimate Mimicker
Presenter:
Date
05/22/2019
Room
Area A (Hall F, Level 2), KBHCCD
Session Name
D48 - CRITICAL CARE CASE REPORTS: INFECTION AND SEPSIS II
A2091 - Prolonged LPS Exposure Caused Increased IL-1B Release in TREK-1 Deficient Macrophages Independent of NLRP3
Presenter:
Date
05/19/2019
Room
Area C (Hall F, Level 2), KBHCCD
Session Name
A60 - LUNG INJURY, SEPSIS, AND ARDS
A3867 - Characteristics of Airflow and Particle Deposition in Airway Variants Among Smokers and Non-Smokers
Presenter:
Date
05/20/2019
Room
Area D (Hall F, Level 2), KBHCCD
Session Name
B64 - COPD: MECHANISM AND TREATMENT
A4384 - Evaluation of Pulmonary Nodules in Pediatric Patients with Active Oncologic Diagnoses
Presenter:
Date
05/21/2019
Room
Trinity Ballroom 1-3 (Level 3), Omni Dallas Downtown
Session Name
C25 - CLINICAL AND TRANSLATIONAL STUDIES IN RARE LUNG DISEASE
A5935 - Patient Decision-Making Around Use of Reliever Inhalers in Mild Asthma
Presenter:
Date
05/22/2019
Room
Trinity Ballroom 5-7 (Level 3), Omni Dallas Downtown
Session Name
D22 - REAL WORLD MEDICATION USE IN PULMONARY DISEASES
A6106 - Assessment of Asthma in Children Using Electromyography
Presenter:
Date
05/22/2019
Room
Ballroom D Three (Level 3), KBHCCD
Session Name
D30 - ASTHMA: WHAT’S NEW IN ASSESSMENT AND TREATMENT?
Authors